Nova Leap Health (TSXV:NLH) is Growing by Leaps and Bounds: Ubika Research

Nova Leap Initiation Report Healthcare: Canadian Small Cap September 18, 2018
Alp Erdogan, MBA | Analyst | Ubika Research Alp@UbikaResearch.com | 1 (647) 479-5690
Alexander Cardno | Associate | Ubika Research Alexander@UbikaResearch.com | 1 (519) 781-2426

”Nova

Market Data (TSXV:NLH)

Price (September 18, 2018) $0.35

52 Week Range$0.14 – $0.45

Market Cap $18M

Fully Diluted Current Shares Outstanding68.9M

Free Float 56%

Average Daily Volume (3 Months)33.5K

Total Debt* US$3.9M

Cash*US$1.6M

Total Current Assets* US$2.9M

Revenue (FY2016) US$0.1M

Revenue (FY2017) US$1.1M

Revenue (FY2018E)US$10.4M

Revenue (FY2019E)US$16.0M**

Headquarters Halifax, Nova Scotia, Canada

Website https://novaleaphealth.com/

Top Shareholders

Wayne Fulcher 17.3%

Chris Dobbin12.7%

Dana Hartfield 4.7%

Michael O’Keefe2.8%

Wayne Myles
1.6%

Management

Chris Dobbin, CPA, CA President, CEO

Megan Spidle, CPA, CACEO

Dana Hatfield, CPA, CALead Indep. Director

Michael O’Keefe, MBA, CPAIndependent Director

Wayne MylesIndependent Director

*as of September 18, 2018 ** based solely on organic growth, excluding M&A All figures in CAD unless otherwise stated. Source: Company Reports, Thomson Reuters

Price Performance

Nova Leap Health Corp. (TSXV:NLH)

Company Description

Nova Leap Health Corp. (TSXV:NLH) is a North American provider of personal home care and support services. The Company is focused on acquiring and organically growing home healthcare companies. Nova Leap’s post-acquisition growth strategy is to increase annual revenue per location through a combination of increased employee investment, including training, focused sales and marketing efforts, billing rate growth and expansion of geographical coverage.

Investment Highlights

  • The Home Care Providers industry is one of the fastest-growing healthcare verticals in Canada and the United States. Home care saves patients billions of dollars every year by treating them in their own homes as opposed to hospital settings. Industry growth is driven by secular trends such as an aging population, shift towards chronic disease management, focus on cost-effective treatment options in the private and public pay space as well as growing physician acceptance of home healthcare.
  • The U.S. Home Healthcare market is worth US$89.2B, of which the NonMedical Home Care bucket accounts for 6.1%, with a size of US$5.4B. The marketplace is highly fragmented, with more than 90% of industry establishments comprising of sole proprietorships. Furthermore, no industry player accounts for more than ~5% of industry revenue. As an accretive M&Adriven pure play in the space, Nova Leap offers investors a compelling story with an attractive risk/reward profile for the next 12-24 months.
  • Nova Leap Health continues to execute on its corporate M&A strategy. The Company has focused on acquiring and organically growing Private Pay NonMedical and Skilled Home Care companies, and the recent deal announcements illustrate that management continues to find investment opportunities at attractive takeout multiples. Nova Leap is beginning to realize economies of scale by successfully integrating within its growth-by-acquisition model and expects to be profitable on a consolidated basis by year-end.

Financial Highlights & Valuation

  • On a relative valuation basis, Nova Leap Health stock currently trades at 1.4x forward EV/Sales, a discount to 1.6x commanded by its industry peers. Management has guided to a FY2018 annual revenue run rate of US$14M – US$15M. With its two most recent acquisition announcements, the Company should exceed US$15M. We opine that at current levels, NLH offers equity investors a compelling growth story in the next 12-24 months, given the disciplined M&A platform, efficient capital allocation and strong execution by an experienced management team.

To find out more about Nova Leap Health, please visit the company’s Investor Hub.

Nova Leap Health Corp. (TSXV:NLH) is a featured sponsored company and has paid SmallCapPower.com a fee for coverage. To learn more, see our full disclosure HERE >>

To read our full disclosure, please click on the button below:

The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.